Akoya Biosciences Inc (AKYA)
2.49
-0.64
(-20.45%)
USD |
NASDAQ |
Nov 15, 11:40
Akoya Biosciences Cash from Financing (Quarterly): -2.125M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -2.125M |
| March 31, 2024 | -0.444M |
| December 31, 2023 | 11.08M |
| September 30, 2023 | -0.141M |
| June 30, 2023 | 46.33M |
| March 31, 2023 | -0.419M |
| December 31, 2022 | 10.27M |
| September 30, 2022 | 9.86M |
| June 30, 2022 | 8.667M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.071M |
| December 31, 2021 | 0.149M |
| September 30, 2021 | -0.044M |
| June 30, 2021 | 136.93M |
| March 31, 2021 | -0.004M |
| December 31, 2020 | 5.687M |
| September 30, 2020 | 0.04M |
| June 30, 2020 | 2.419M |
| March 31, 2020 | -2.66M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.66M
Minimum
Mar 2020
136.93M
Maximum
Jun 2021
12.53M
Average
0.0945M
Median
Cash from Financing (Quarterly) Benchmarks
| Bruker Corp | -2.70M |
| Azenta Inc | -224.44M |
| Harvard Bioscience Inc | 2.104M |
| Bionano Genomics Inc | -1.978M |
| Singular Genomics Systems Inc | 0.08M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.04M |
| Cash from Investing (Quarterly) | 9.054M |
| Free Cash Flow | -53.61M |
| Free Cash Flow Per Share (Quarterly) | -0.2269 |
| Free Cash Flow to Equity (Quarterly) | -11.43M |
| Free Cash Flow to Firm (Quarterly) | -9.266M |
| Free Cash Flow Yield | -43.66% |